Literature DB >> 32065704

How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade.

Kyle R Jackson1, Jennifer D Motter1, Amber Kernodle1, Niraj Desai1, Alvin G Thomas1, Allan B Massie1,2, Jacqueline M Garonzik-Wang1, Dorry L Segev1,2,3.   

Abstract

Prioritization of highly sensitized (HS) candidates under the kidney allocation system (KAS) and growth of large, multicenter kidney-paired donation (KPD) clearinghouses have broadened the transplant modalities available to HS candidates. To quantify temporal trends in utilization of these modalities, we used SRTR data from 2009 to 2017 to study 39 907 adult HS (cPRA ≥ 80%) waitlisted candidates and 19 003 recipients. We used competing risks regression to quantify temporal trends in likelihood of DDKT, KPD, and non-KPD LDKT for HS candidates (Era 1: January 1, 2009-December 31, 2011; Era 2: January 1, 2012-December 3, 2014; Era 3: December 4, 2014-December 31, 2017). Although the likelihood of DDKT and KPD increased over time for all HS candidates (adjusted subhazard ratio [aSHR] Era 3 vs 1 for DDKT: 1.74 1.851.97 , P < .001 and for KPD: 1.70 2.202.84 , P < .001), the likelihood of non-KPD LDKT decreased (aSHR: 0.69 0.820.97 , P = .02). However, these changes affected HS recipients differently based on cPRA. Among recipients, more cPRA 98%-99.9% and 99.9%+ recipients underwent DDKT (96.2% in Era 3% vs 59.1% in Era 1 for cPRA 99.9%+), whereas fewer underwent non-KPD LDKT (1.9% vs 30.9%) or KPD (2.0% vs 10.0%). Although KAS increased DDKT likelihood for the most HS candidates, it also decreased the use of non-KPD LDKT to transplant cPRA 98%+ candidates.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; donors and donation: deceased; donors and donation: paired exchange; health services and outcomes research; kidney transplantation/nephrology; panel reactive antibody (PRA); registry/registry analysis

Mesh:

Year:  2020        PMID: 32065704      PMCID: PMC8717833          DOI: 10.1111/ajt.15825

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  27 in total

1.  The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.

Authors:  D Axelrod; K L Lentine; M A Schnitzler; X Luo; H Xiao; B J Orandi; A Massie; J Garonzik-Wang; M D Stegall; S C Jordan; J Oberholzer; T B Dunn; L E Ratner; S Kapur; R P Pelletier; J P Roberts; M L Melcher; P Singh; D L Sudan; M P Posner; J M El-Amm; R Shapiro; M Cooper; G S Lipkowitz; M A Rees; C L Marsh; B R Sankari; D A Gerber; P W Nelson; J Wellen; A Bozorgzadeh; A Osama Gaber; R A Montgomery; D L Segev
Journal:  Am J Transplant       Date:  2017-07-21       Impact factor: 8.086

2.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

3.  Living donor age and kidney allograft half-life: implications for living donor paired exchange programs.

Authors:  Peter Chang; Jagbir Gill; James Dong; Caren Rose; Howard Yan; David Landsberg; Edward H Cole; John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

4.  Kidney exchange match rates in a large multicenter clearinghouse.

Authors:  Courtenay M Holscher; Kyle Jackson; Eric K H Chow; Alvin G Thomas; Christine E Haugen; Sandra R DiBrito; Carlin Purcell; Matthew Ronin; Amy D Waterman; Jacqueline Garonzik Wang; Allan B Massie; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-03-09       Impact factor: 8.086

5.  New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.

Authors:  Michelle J Hickey; Ying Zheng; Nicole Valenzuela; Qiuheng Zhang; Carolyn Krystal; Erik Lum; Eileen W Tsai; Gerald S Lipshutz; H Albin Gritsch; Gabriel Danovitch; Jeffrey Veale; David Gjertson; Michael Cecka; Elaine F Reed
Journal:  Hum Immunol       Date:  2016-11-03       Impact factor: 2.850

Review 6.  Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States.

Authors:  Ronald F Parsons; Jayme E Locke; Robert R Redfield; Garrett R Roll; Matthew H Levine
Journal:  Hum Immunol       Date:  2016-10-20       Impact factor: 2.850

7.  Characterization of waiting times in a simulation of kidney paired donation.

Authors:  Dorry L Segev; Sommer E Gentry; J Keith Melancon; Robert A Montgomery
Journal:  Am J Transplant       Date:  2005-10       Impact factor: 8.086

8.  Probability of deceased donor kidney transplantation based on % PRA.

Authors:  I C Bostock; J Alberú; A Arvizu; E A Hernández-Mendez; A De-Santiago; N González-Tableros; M López; N Castelán; A G Contreras; L E Morales-Buenrostro; B Gabilondo; M Vilatobá
Journal:  Transpl Immunol       Date:  2013-05-16       Impact factor: 1.708

9.  The first 9 years of kidney paired donation through the National Kidney Registry: Characteristics of donors and recipients compared with National Live Donor Transplant Registries.

Authors:  Stuart M Flechner; Alvin G Thomas; Matthew Ronin; Jeffrey L Veale; David B Leeser; Sandip Kapur; John D Peipert; Dorry L Segev; Macey L Henderson; Ashton A Shaffer; Matthew Cooper; Garet Hil; Amy D Waterman
Journal:  Am J Transplant       Date:  2018-04-30       Impact factor: 8.086

Review 10.  Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients.

Authors:  Krista L Lentine; David Axelrod; Christina Klein; Christopher Simpkins; Huiling Xiao; Mark A Schnitzler; Janet E Tuttle-Newhall; Vikas R Dharnidharka; Daniel C Brennan; Dorry L Segev
Journal:  Transplantation       Date:  2014-07-15       Impact factor: 4.939

View more
  7 in total

Review 1.  Principles of Virtual Crossmatch Testing for Kidney Transplantation.

Authors:  Madhu C Bhaskaran; Sebastiaan Heidt; Thangamani Muthukumar
Journal:  Kidney Int Rep       Date:  2022-03-15

2.  Impact of low-level pretransplant donor-specific antibodies on outcomes after kidney transplantation.

Authors:  Sandesh Parajuli; Natalie M Bath; Luis Hidalgo; Glen Leverson; Neetika Garg; Robert R Redfield; Didier A Mandelbrot
Journal:  Immun Inflamm Dis       Date:  2021-08-18

3.  Immortal Time-Bias-Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients.

Authors:  Johan Noble; Antoine Metzger; Melanie Daligault; Eloi Chevallier; Mathilde Bugnazet; Beatrice Bardy; Hamza Naciri Bennani; Nicolas Terrier; Gaelle Fiard; Quentin Franquet; Benedicte Janbon; Dominique Masson; Diane Giovannini; Paolo Malvezzi; Thomas Jouve; Lionel Rostaing
Journal:  Kidney Int Rep       Date:  2021-08-02

4.  Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation.

Authors:  Mason Phillpott; Sunil Daga; Rob Higgins; David Lowe; Nithya Krishnan; Daniel Zehnder; David Briggs; Natalia Khovanova
Journal:  Transpl Int       Date:  2022-04-11       Impact factor: 3.842

5.  Imlifidase-generated Single-cleaved IgG: Implications for Transplantation.

Authors:  Robert Bockermann; Sofia Järnum; Anna Runström; Tomas Lorant; Lena Winstedt; Niklas Palmqvist; Christian Kjellman
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

6.  The first increase in live kidney donation in the United States in 15 years.

Authors:  Fawaz Al Ammary; Yifan Yu; Alexander Ferzola; Jennifer D Motter; Allan B Massie; Sile Yu; Alvin G Thomas; Deidra C Crews; Dorry L Segev; Abimereki D Muzaale; Macey L Henderson
Journal:  Am J Transplant       Date:  2020-07-17       Impact factor: 8.086

7.  Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.

Authors:  Christian Kjellman; Angela Q Maldonado; Kristoffer Sjöholm; Bonnie E Lonze; Robert A Montgomery; Anna Runström; Tomas Lorant; Niraj M Desai; Christophe Legendre; Torbjörn Lundgren; Bengt von Zur Mühlen; Ashley A Vo; Håkan Olsson; Stanley C Jordan
Journal:  Am J Transplant       Date:  2021-07-19       Impact factor: 9.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.